United States · 
Who invested in Carlsmed?
Carlsmed's investors include B Capital and Wavemaker Three-Sixty Health.
United States · Series C startup
Who invested in Carlsmed
Funding summaryUpdated 26 Oct 2026
$65Mraised across 1 round since 2024, from 1 source
- Latest round
- Series C, $65MMar 2024
- Investors
- 2
The rounds
- Mar 2024Series C$65M
Source recordedSEC filing: $38M sold, first sale Mar 2024
Founders and team
From Carlsmed's own website: 8 on the team.
- Mike CordonnierChief Executive Officer
- Julie LamotheSenior Vice President, Quality & Regulatory Affairs
- Anthony JarcChief Product and AI Officer
- Jeff BertoliniChief Operating Officer
- Jennifer KamocsayChief Legal Officer
- Richard HeppenstallChief Financial Officer
- Scott DurallChief Commercial Officer
- Sharon SchulzkiChief Clinical & Market Access Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Carlsmed as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Carlsmed
How much has Carlsmed raised?
Carlsmed has raised $65M across 1 round since 2024.
When did Carlsmed last raise?
Carlsmed's most recent round was a Series C of $65M in Mar 2024.
What was Carlsmed's biggest round?
Its most recent round, $65M in Mar 2024, is also its largest on record.
Who backed Carlsmed first?
Carlsmed's first round on record, in Mar 2024, was backed by B Capital and Wavemaker Three-Sixty Health.
What stage is Carlsmed at?
Carlsmed's latest named round is a Series C, in Mar 2024.
Where is Carlsmed based?
Carlsmed is based in the United States.
Companies like Carlsmed
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.